2002/09/01 by Manfréd M. Fischer, Gynter Mödder · 79 citations
Medicine · #Rheumatoid Arthritis Research and Therapies #Radiopharmaceutical Chemistry and Applications #HER2/EGFR in Cancer Research #Medicine #Rheumatoid arthritis #Synovectomy #Joint disease #Knee Joint #Arthropathy #Arthritis #Synovial joint #Joint (building) #Inflammatory arthritis #Radionuclide therapy #Osteoarthritis #Surgery #Internal medicine #Pathology
paper · doi:10.1097/00006231-200209000-00003
published in Nuclear Medicine Communications 23(9), 829-831 (Lippincott Williams & Wilkins)
openalex publication_date 2002/09/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/06/11
Inflammatory joint diseases as well as arthropathy are common joint diseases. Many of them may be treated by synovectomy to stop disease progression and to improve joint function. Radiosynoviorthesis as one therapeutic procedure of rheumatoid arthritis, other inflammatory joint diseases, persistent synovial perfusion, and other joint diseases is widely used in many countries in Europe. Using Y-90 for the knee joint, Re-186 for middle sized joints and Er-169 for small joints an improvement of symptoms and function may be observed in about 60-80% of patients.